Latest oppositions filed by Symbiosis Ip Limited

This table presents recent patent oppositions filed by Symbiosis Ip Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3498734Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME CORP.May 26, 2022
EP3283882Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 AntagonistsMERCK SHARP & DOHME CORP.Sep 15, 2021